0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover138.60%IV-31.15%PremiumAug 16, 2024Expiry Date2.38Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7154Delta0.1252Gamma2.77Leverage Ratio-0.0181Theta-0.0045Rho-1.98Eff Leverage0.0067Vega
MiMedx Stock Discussion
In a recent move that underscores their confidence in the regenerative medicine sector, Mizuho Securities has maintained its 'Buy' rating on MiMedx Group Inc. (NASDAQ: MDXG) and has raised the price target from a previous estimate to $14. This comes as the company continues to make significant strides in its advanced wound care and surgical tissue solutions. $MiMedx(MDXG.US)$